The Effect of Subconjunctival Ranibizumab on Corneal and Anterior Segment Neovascularization: Study on an Animal Model

The Impact of Subconjuctivally Injected EGF and VEGF Inhibitors on Experimental Corneal Neovascularization in Rat Model

(2012) Ender Sener et al.   CURRENT EYE RESEARCH

Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable

(2011) Claus Cursiefen et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Combined Use of Subconjunctival and Intracorneal Bevacizumab Injection for Corneal Neovascularization

(2011) Sonia N Yeung et al.   CORNEA

Subconjunctival bevacizumab for corneal neovascularization secondary to topical anesthetic abuse

(2011) Constantine D. Georgakopoulos et al.   Cutaneous and Ocular Toxicology

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Prevention of Corneal Neovascularization: Comparison of Different Doses of Subconjunctival Bevacizumab with Its Topical Form in Experimental Rats

(2011) Mohammad Naser Hashemian et al.   OPHTHALMIC RESEARCH

Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study

(2011) David M. Brown et al.   OPHTHALMOLOGY

Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study

(2011) Peter A. Campochiaro et al.   OPHTHALMOLOGY

The RESTORE Study

(2011) Paul Mitchell et al.   OPHTHALMOLOGY

INTRAVITREAL RANIBIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION

(2011) Sarah M Risard et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Phase I Study of Subconjunctival Ranibizumab in Patients With Primary Pterygium Undergoing Pterygium Surgery

(2010) Anat Galor et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

The Effect of Subconjunctival Ranibizumab on Primary Pterygium: A Pilot Study

(2010) Achilleas Mandalos et al.   CORNEA

Association of ranibizumab (Lucentis®) or bevacizumab (Avastin®) with dexamethasone and triamcinolone acetonide: An in vitro stability assessment

(2010) Marieke Veurink et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Novel aspects of corneal angiogenic and lymphangiogenic privilege

(2010) David Ellenberg et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Topical Bevacizumab in the Treatment of Corneal Neovascularization

(2009) Mohammad H. Dastjerdi   ARCHIVES OF OPHTHALMOLOGY

Treatment of inflamed pterygia or residual pterygial bed

(2009) A M Mansour   BRITISH JOURNAL OF OPHTHALMOLOGY

Subconjunctival Bevacizumab Injection for Corneal Neovascularization

(2009) Irit Bahar et al.   CORNEA

Inhibition of Experimental Corneal Neovascularization by Using Subconjunctival Injection of Bevacizumab (Avastin)

(2009) Tae-im Kim et al.   CORNEA

Herpes Simplex Virus Keratitis: Histopathologic Neovascularization and Corneal Allograft Failure

(2009) Denise D Garcia et al.   CORNEA

Inhibition of Corneal Neovascularization by Subconjunctival Bevacizumab in an Animal Model

(2008) Miltiadis Papathanassiou et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

The Effect of Topical Bevacizumab on Corneal Neovascularization

(2008) Sang Woo Kim et al.   OPHTHALMOLOGY

Intravitreal Bevacizumab to Treat Iris Neovascularization and Neovascular Glaucoma Secondary to Ischemic Retinal Diseases in 41 Consecutive Cases

(2008) Taku Wakabayashi et al.   OPHTHALMOLOGY